APO Research
Talk to an analyst

APO RESEARCH · REPORT

Zika Vaccines

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Zika Vaccines Industry Growth and Trends Forecast to 2032

20 December 202599 pages

Choose your research edition.

Industry ResearchZika Vaccines Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Zika Vaccines Industry Growth and Trends Forecast to 203299 pages · $3,450 USDMarket StructureGlobal Zika Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032181 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Zika Vaccines Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Zika Vaccines Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Zika Vaccines market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Zika Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Zika Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Zika Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Zika Vaccines include Sanofi, GlaxoSmithKline, NewLink Genetics, Inovio Pharmaceuticals, Immunovaccine, Cerus Corporation and Bharat Biotech, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Zika Vaccines market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Zika Vaccines market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Zika Vaccines market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Zika Vaccines.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Zika Vaccines market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Zika Vaccines Market by Company

Sanofi

GlaxoSmithKline

NewLink Genetics

Inovio Pharmaceuticals

Immunovaccine

Cerus Corporation

Bharat Biotech

Zika Vaccines Segment by Type

Therapeutic Vaccines

Preventive Vaccines

Zika Vaccines Segment by Application

Clinics

Hospitals

Ambulatory Surgery Centers

Others

Zika Vaccines Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Zika Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Zika Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Zika Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Zika Vaccines manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Zika Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Therapeutic Vaccines Table 2. Major Company of Preventive Vaccines Table 3. Global Zika Vaccines Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Zika Vaccines Sales by Type (2021-2026) & (k units) Table 5. Global Zika Vaccines Sales Market Share in Volume by Type (2021-2026) Table 6. Global Zika Vaccines Sales by Type (2021-2026) & (US$ Million) Table 7. Global Zika Vaccines Sales Market Share in Value by Type (2021-2026) Table 8. Global Zika Vaccines Price by Type (2021-2026) & (US$/unit) Table 9. Global Zika Vaccines Sales by Type (2027-2032) & (k units) Table 10. Global Zika Vaccines Sales Market Share in Volume by Type (2027-2032) Table 11. Global Zika Vaccines Sales by Type (2027-2032) & (US$ Million) Table 12. Global Zika Vaccines Sales Market Share in Value by Type (2027-2032) Table 13. Global Zika Vaccines Price by Type (2027-2032) & (US$/unit) Table 14. North America Zika Vaccines Sales by Type (2021-2026) & (k units) Table 15. North America Zika Vaccines Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Zika Vaccines Sales by Type (2021-2026) & (k units) Table 17. Europe Zika Vaccines Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Zika Vaccines Sales by Type (2021-2026) & (k units) Table 19. Asia-Pacific Zika Vaccines Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Zika Vaccines Sales by Type (2021-2026) & (k units) Table 21. Latin America Zika Vaccines Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Zika Vaccines Sales by Type (2021-2026) & (k units) Table 23. Middle East and Africa Zika Vaccines Sales by Type (2021-2026) & (US$ Million) Table 24. Zika Vaccines Industry Trends Table 25. Zika Vaccines Industry Drivers Table 26. Zika Vaccines Industry Opportunities and Challenges Table 27. Zika Vaccines Industry Restraints Table 28. Global Zika Vaccines Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Zika Vaccines Revenue Market Share by Company (2021-2026) Table 30. Global Zika Vaccines Sales by Company (2021-2026) & (k units) Table 31. Global Zika Vaccines Sales Share by Company (2021-2026) Table 32. Global Zika Vaccines Market Price by Company (2021-2026) & (US$/unit) Table 33. Global Zika Vaccines Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Zika Vaccines Major Company Production Sites and Headquarters Table 35. Global Zika Vaccines Company, Product Type & Application Table 36. Global Zika Vaccines Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Zika Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Zika Vaccines Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Zika Vaccines Sales by Region (2021-2026) & (k units) Table 41. Global Zika Vaccines Sales Market Share in Volume by Region (2021-2026) Table 42. Global Zika Vaccines Sales by Region (2021-2026) & (US$ Million) Table 43. Global Zika Vaccines Sales Market Share in Value by Region (2021-2026) Table 44. Global Zika Vaccines Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 45. Global Zika Vaccines Sales by Region (2027-2032) & (k units) Table 46. Global Zika Vaccines Sales Market Share in Volume by Region (2027-2032) Table 47. Global Zika Vaccines Sales by Region (2027-2032) & (US$ Million) Table 48. Global Zika Vaccines Sales Market Share in Value by Region (2027-2032) Table 49. Global Zika Vaccines Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 50. Global Zika Vaccines Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Zika Vaccines Sales by Application (2021-2026) & (k units) Table 52. Global Zika Vaccines Sales Market Share in Volume by Application (2021-2026) Table 53. Global Zika Vaccines Sales by Application (2021-2026) & (US$ Million) Table 54. Global Zika Vaccines Sales Market Share in Value by Application (2021-2026) Table 55. Global Zika Vaccines Price by Application (2021-2026) & (US$/unit) Table 56. Global Zika Vaccines Sales by Application (2027-2032) & (k units) Table 57. Global Zika Vaccines Sales Market Share in Volume by Application (2027-2032) Table 58. Global Zika Vaccines Sales by Application (2027-2032) & (US$ Million) Table 59. Global Zika Vaccines Sales Market Share in Value by Application (2027-2032) Table 60. Global Zika Vaccines Price by Application (2027-2032) & (US$/unit) Table 61. North America Zika Vaccines Sales by Application (2021-2026) & (k units) Table 62. North America Zika Vaccines Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Zika Vaccines Sales by Application (2021-2026) & (k units) Table 64. Europe Zika Vaccines Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Zika Vaccines Sales by Application (2021-2026) & (k units) Table 66. Asia-Pacific Zika Vaccines Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Zika Vaccines Sales by Application (2021-2026) & (k units) Table 68. Latin America Zika Vaccines Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Zika Vaccines Sales by Application (2021-2026) & (k units) Table 70. Middle East and Africa Zika Vaccines Sales by Application (2021-2026) & (US$ Million) Table 71. Sanofi Company Information Table 72. Sanofi Business Overview Table 73. Sanofi Zika Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Sanofi Zika Vaccines Product Portfolio Table 75. Sanofi Recent Development Table 76. GlaxoSmithKline Company Information Table 77. GlaxoSmithKline Business Overview Table 78. GlaxoSmithKline Zika Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. GlaxoSmithKline Zika Vaccines Product Portfolio Table 80. GlaxoSmithKline Recent Development Table 81. NewLink Genetics Company Information Table 82. NewLink Genetics Business Overview Table 83. NewLink Genetics Zika Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. NewLink Genetics Zika Vaccines Product Portfolio Table 85. NewLink Genetics Recent Development Table 86. Inovio Pharmaceuticals Company Information Table 87. Inovio Pharmaceuticals Business Overview Table 88. Inovio Pharmaceuticals Zika Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. Inovio Pharmaceuticals Zika Vaccines Product Portfolio Table 90. Inovio Pharmaceuticals Recent Development Table 91. Immunovaccine Company Information Table 92. Immunovaccine Business Overview Table 93. Immunovaccine Zika Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. Immunovaccine Zika Vaccines Product Portfolio Table 95. Immunovaccine Recent Development Table 96. Cerus Corporation Company Information Table 97. Cerus Corporation Business Overview Table 98. Cerus Corporation Zika Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 99. Cerus Corporation Zika Vaccines Product Portfolio Table 100. Cerus Corporation Recent Development Table 101. Bharat Biotech Company Information Table 102. Bharat Biotech Business Overview Table 103. Bharat Biotech Zika Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 104. Bharat Biotech Zika Vaccines Product Portfolio Table 105. Bharat Biotech Recent Development Table 106. North America Zika Vaccines Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 107. North America Zika Vaccines Sales by Country (2021-2026) & (k units) Table 108. North America Zika Vaccines Sales Market Share by Country (2021-2026) Table 109. North America Zika Vaccines Sales Forecast by Country (2027-2032) & (k units) Table 110. North America Zika Vaccines Sales Market Share Forecast by Country (2027-2032) Table 111. North America Zika Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 112. North America Zika Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 113. North America Zika Vaccines Market Share by Country (2021-2026) Table 114. North America Zika Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 115. North America Zika Vaccines Market Share Forecast by Country (2027-2032) Table 116. Europe Zika Vaccines Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 117. Europe Zika Vaccines Sales by Country (2021-2026) & (k units) Table 118. Europe Zika Vaccines Sales Market Share by Country (2021-2026) Table 119. Europe Zika Vaccines Sales Forecast by Country (2027-2032) & (k units) Table 120. Europe Zika Vaccines Sales Market Share Forecast by Country (2027-2032) Table 121. Europe Zika Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 122. Europe Zika Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 123. Europe Zika Vaccines Market Share by Country (2021-2026) Table 124. Europe Zika Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 125. Europe Zika Vaccines Market Share Forecast by Country (2027-2032) Table 126. Asia-Pacific Zika Vaccines Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 127. Asia-Pacific Zika Vaccines Sales by Country (2021-2026) & (k units) Table 128. Asia-Pacific Zika Vaccines Sales Market Share by Country (2021-2026) Table 129. Asia-Pacific Zika Vaccines Sales Forecast by Country (2027-2032) & (k units) Table 130. Asia-Pacific Zika Vaccines Sales Market Share Forecast by Country (2027-2032) Table 131. Asia-Pacific Zika Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. Asia-Pacific Zika Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 133. Asia-Pacific Zika Vaccines Market Share by Country (2021-2026) Table 134. Asia-Pacific Zika Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. Asia-Pacific Zika Vaccines Market Share Forecast by Country (2027-2032) Table 136. Latin America Zika Vaccines Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 137. Latin America Zika Vaccines Sales by Country (2021-2026) & (k units) Table 138. Latin America Zika Vaccines Sales Market Share by Country (2021-2026) Table 139. Latin America Zika Vaccines Sales Forecast by Country (2027-2032) & (k units) Table 140. Latin America Zika Vaccines Sales Market Share Forecast by Country (2027-2032) Table 141. Latin America Zika Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. Latin America Zika Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 143. Latin America Zika Vaccines Market Share by Country (2021-2026) Table 144. Latin America Zika Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. Latin America Zika Vaccines Market Share Forecast by Country (2027-2032) Table 146. Middle East and Africa Zika Vaccines Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 147. Middle East and Africa Zika Vaccines Sales by Country (2021-2026) & (k units) Table 148. Middle East and Africa Zika Vaccines Sales Market Share by Country (2021-2026) Table 149. Middle East and Africa Zika Vaccines Sales Forecast by Country (2027-2032) & (k units) Table 150. Middle East and Africa Zika Vaccines Sales Market Share Forecast by Country (2027-2032) Table 151. Middle East and Africa Zika Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Middle East and Africa Zika Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 153. Middle East and Africa Zika Vaccines Market Share by Country (2021-2026) Table 154. Middle East and Africa Zika Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Middle East and Africa Zika Vaccines Market Share Forecast by Country (2027-2032) Table 156. Key Raw Materials Table 157. Raw Materials Key Suppliers Table 158. Zika Vaccines Distributors List Table 159. Zika Vaccines Customers List Table 160. Research Programs/Design for This Report Table 161. Authors List of This Report Table 162. Secondary Sources Table 163. Primary Sources List of Figures Figure 1. Zika Vaccines Image Figure 2. Global Zika Vaccines Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Zika Vaccines Market Size (2021-2032) & (US$ Million) Figure 4. Global Zika Vaccines Sales (2021-2032) & (k units) Figure 5. Therapeutic Vaccines Image Figure 6. Global Therapeutic Vaccines Sales YoY Growth (2021-2032) & (k units) Figure 7. Preventive Vaccines Image Figure 8. Global Preventive Vaccines Sales YoY Growth (2021-2032) & (k units) Figure 9. Global Zika Vaccines Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Zika Vaccines Market Share by Type 2025 VS 2032 Figure 11. North America Zika Vaccines Sales Market Share in Volume by Type in 2025 Figure 12. North America Zika Vaccines Sales Market Share in Value by Type in 2025 Figure 13. Europe Zika Vaccines Sales Market Share in Volume by Type in 2025 Figure 14. Europe Zika Vaccines Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Zika Vaccines Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Zika Vaccines Sales Market Share in Value by Type in 2025 Figure 17. Latin America Zika Vaccines Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Zika Vaccines Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Zika Vaccines Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Zika Vaccines Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Zika Vaccines Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Clinics Image Figure 24. Global Clinics Sales YoY Growth (2021-2032) & (k units) Figure 25. Hospitals Image Figure 26. Global Hospitals Sales YoY Growth (2021-2032) & (k units) Figure 27. Ambulatory Surgery Centers Image Figure 28. Global Ambulatory Surgery Centers Sales YoY Growth (2021-2032) & (k units) Figure 29. Others Image Figure 30. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 31. Global Zika Vaccines Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Zika Vaccines Market Share by Application 2025 VS 2032 Figure 33. North America Zika Vaccines Sales Market Share in Volume by Application in 2025 Figure 34. North America Zika Vaccines Sales Market Share in Value by Application in 2025 Figure 35. Europe Zika Vaccines Sales Market Share in Volume by Application in 2025 Figure 36. Europe Zika Vaccines Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Zika Vaccines Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Zika Vaccines Sales Market Share in Value by Application in 2025 Figure 39. Latin America Zika Vaccines Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Zika Vaccines Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Zika Vaccines Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Zika Vaccines Sales Market Share in Value by Application in 2025 Figure 43. North America Zika Vaccines Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 44. North America Zika Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Zika Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Zika Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Zika Vaccines Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 48. Europe Zika Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Zika Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Zika Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Zika Vaccines Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 52. Asia-Pacific Zika Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Zika Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Zika Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Zika Vaccines Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 56. Latin America Zika Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Zika Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Zika Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Zika Vaccines Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 60. Middle East and Africa Zika Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Zika Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Zika Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Zika Vaccines Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Zika Vaccines Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Therapeutic Vaccines
  • Preventive Vaccines
Applications
  • Clinics
  • Hospitals
  • Ambulatory Surgery Centers
  • Others
Companies covered
  • Sanofi
  • GlaxoSmithKline
  • NewLink Genetics
  • Inovio Pharmaceuticals
  • Immunovaccine
  • Cerus Corporation
  • Bharat Biotech

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Zika Vaccines Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Zika Vaccines Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Zika Vaccines Market by Type
  6. 1.3.1 Therapeutic Vaccines
  7. 1.3.2 Preventive Vaccines
  8. 1.4 Global Zika Vaccines Market Size by Type
  9. 1.4.1 Global Zika Vaccines Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Zika Vaccines Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Zika Vaccines Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Zika Vaccines Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Zika Vaccines Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Zika Vaccines Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Zika Vaccines Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Zika Vaccines Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Zika Vaccines Industry Trends
  2. 2.2 Zika Vaccines Industry Drivers
  3. 2.3 Zika Vaccines Industry Opportunities and Challenges
  4. 2.4 Zika Vaccines Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Zika Vaccines Revenue (2021-2026)
  2. 3.2 Global Top Players by Zika Vaccines Sales (2021-2026)
  3. 3.3 Global Top Players by Zika Vaccines Price (2021-2026)
  4. 3.4 Global Zika Vaccines Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Zika Vaccines Major Company Production Sites & Headquarters
  6. 3.6 Global Zika Vaccines Company, Product Type & Application
  7. 3.7 Global Zika Vaccines Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Zika Vaccines Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Zika Vaccines Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Zika Vaccines Tier 1, Tier 2, and Tier 3
4 Zika Vaccines Regional Status and Outlook
  1. 4.1 Global Zika Vaccines Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Zika Vaccines Historic Market Size by Region
  3. 4.2.1 Global Zika Vaccines Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Zika Vaccines Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Zika Vaccines Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Zika Vaccines Forecasted Market Size by Region
  7. 4.3.1 Global Zika Vaccines Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Zika Vaccines Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Zika Vaccines Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Zika Vaccines by Application
  1. 5.1 Zika Vaccines Market by Application
  2. 5.1.1 Clinics
  3. 5.1.2 Hospitals
  4. 5.1.3 Ambulatory Surgery Centers
  5. 5.1.4 Others
  6. 5.2 Global Zika Vaccines Market Size by Application
  7. 5.2.1 Global Zika Vaccines Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Zika Vaccines Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Zika Vaccines Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Zika Vaccines Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Zika Vaccines Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Zika Vaccines Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Zika Vaccines Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Zika Vaccines Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Sanofi
  2. 6.1.1 Sanofi Company Information
  3. 6.1.2 Sanofi Business Overview
  4. 6.1.3 Sanofi Zika Vaccines Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Sanofi Zika Vaccines Product Portfolio
  6. 6.1.5 Sanofi Recent Developments
  7. 6.2 GlaxoSmithKline
  8. 6.2.1 GlaxoSmithKline Company Information
  9. 6.2.2 GlaxoSmithKline Business Overview
  10. 6.2.3 GlaxoSmithKline Zika Vaccines Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 GlaxoSmithKline Zika Vaccines Product Portfolio
  12. 6.2.5 GlaxoSmithKline Recent Developments
  13. 6.3 NewLink Genetics
  14. 6.3.1 NewLink Genetics Company Information
  15. 6.3.2 NewLink Genetics Business Overview
  16. 6.3.3 NewLink Genetics Zika Vaccines Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 NewLink Genetics Zika Vaccines Product Portfolio
  18. 6.3.5 NewLink Genetics Recent Developments
  19. 6.4 Inovio Pharmaceuticals
  20. 6.4.1 Inovio Pharmaceuticals Company Information
  21. 6.4.2 Inovio Pharmaceuticals Business Overview
  22. 6.4.3 Inovio Pharmaceuticals Zika Vaccines Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Inovio Pharmaceuticals Zika Vaccines Product Portfolio
  24. 6.4.5 Inovio Pharmaceuticals Recent Developments
  25. 6.5 Immunovaccine
  26. 6.5.1 Immunovaccine Company Information
  27. 6.5.2 Immunovaccine Business Overview
  28. 6.5.3 Immunovaccine Zika Vaccines Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Immunovaccine Zika Vaccines Product Portfolio
  30. 6.5.5 Immunovaccine Recent Developments
  31. 6.6 Cerus Corporation
  32. 6.6.1 Cerus Corporation Company Information
  33. 6.6.2 Cerus Corporation Business Overview
  34. 6.6.3 Cerus Corporation Zika Vaccines Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Cerus Corporation Zika Vaccines Product Portfolio
  36. 6.6.5 Cerus Corporation Recent Developments
  37. 6.7 Bharat Biotech
  38. 6.7.1 Bharat Biotech Company Information
  39. 6.7.2 Bharat Biotech Business Overview
  40. 6.7.3 Bharat Biotech Zika Vaccines Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Bharat Biotech Zika Vaccines Product Portfolio
  42. 6.7.5 Bharat Biotech Recent Developments
7 North America by Country
  1. 7.1 North America Zika Vaccines Sales by Country
  2. 7.1.1 North America Zika Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Zika Vaccines Sales by Country (2021-2026)
  4. 7.1.3 North America Zika Vaccines Sales Forecast by Country (2027-2032)
  5. 7.2 North America Zika Vaccines Market Size by Country
  6. 7.2.1 North America Zika Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Zika Vaccines Market Size by Country (2021-2026)
  8. 7.2.3 North America Zika Vaccines Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Zika Vaccines Sales by Country
  2. 8.1.1 Europe Zika Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Zika Vaccines Sales by Country (2021-2026)
  4. 8.1.3 Europe Zika Vaccines Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Zika Vaccines Market Size by Country
  6. 8.2.1 Europe Zika Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Zika Vaccines Market Size by Country (2021-2026)
  8. 8.2.3 Europe Zika Vaccines Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Zika Vaccines Sales by Country
  2. 9.1.1 Asia-Pacific Zika Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Zika Vaccines Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Zika Vaccines Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Zika Vaccines Market Size by Country
  6. 9.2.1 Asia-Pacific Zika Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Zika Vaccines Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Zika Vaccines Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Zika Vaccines Sales by Country
  2. 10.1.1 South America Zika Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Zika Vaccines Sales by Country (2021-2026)
  4. 10.1.3 South America Zika Vaccines Sales Forecast by Country (2027-2032)
  5. 10.2 South America Zika Vaccines Market Size by Country
  6. 10.2.1 South America Zika Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Zika Vaccines Market Size by Country (2021-2026)
  8. 10.2.3 South America Zika Vaccines Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Zika Vaccines Sales by Country
  2. 11.1.1 Middle East and Africa Zika Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Zika Vaccines Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Zika Vaccines Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Zika Vaccines Market Size by Country
  6. 11.2.1 Middle East and Africa Zika Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Zika Vaccines Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Zika Vaccines Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Zika Vaccines Value Chain Analysis
  2. 12.1.1 Zika Vaccines Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Zika Vaccines Production Mode & Process
  7. 12.2 Zika Vaccines Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Zika Vaccines Distributors
  10. 12.2.3 Zika Vaccines Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst